Breaking News Instant updates and real-time market news.

MCD

McDonald's

$157.00

2.945 (1.91%)

, PM

Philip Morris

$111.70

0.0865 (0.08%)

10:38
09/28/17
09/28
10:38
09/28/17
10:38

On The Fly: Top five analyst upgrades

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. McDonald's (MCD) upgraded to Buy from Neutral at Longbow with analyst Alton Stump citing better than expected third quarter U.S. comparable store sales trends. 2. Philip Morris (PM) upgraded to Conviction Buy from Buy at Goldman Sachs with analyst Judy Hong saying the company offers a "rare innovation product cycle story within Staples" along with the strongest global positioning in next generation products. 3. BlackRock (BLK) upgraded to Conviction Buy from Buy at Goldman Sachs with analyst Alexander Blostein saying he expects an acceleration in annual operating income growth given improving trends in active, easing pressures on blended fee rates, and scaling of its tech platform which should lead to sustainable multiple improvement. 4. Potbelly (PBPB) upgraded to Overweight from Neutral at Piper Jaffray with analyst Nicole Miller Regan saying she believes a "compelling" turnaround is building. 5. Huntsman (HUN) upgraded to Outperform from Market Perform at Wells Fargo with analyst Frank Mitsch saying the recent weakness in the shares is a buying opportunity. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

MCD

McDonald's

$157.00

2.945 (1.91%)

PM

Philip Morris

$111.70

0.0865 (0.08%)

BLK

BlackRock

$441.64

3.24 (0.74%)

PBPB

Potbelly

$11.50

-0.1 (-0.86%)

HUN

Huntsman

$26.92

-0.02 (-0.07%)

  • 02

    Oct

  • 11

    Oct

  • 22

    Oct

MCD McDonald's
$157.00

2.945 (1.91%)

09/28/17
LBOW
09/28/17
UPGRADE
Target $183
LBOW
Buy
McDonald's upgraded to Buy from Neutral at Longbow
Longbow analyst Alton Stump upgraded McDonald's to Buy with a $183 price target following better than expected Q3 US comp trends. The analyst raised estimate and said shares deserve to trade above its historical multiple given the ongoing turnaround story in both the US and internationally.
09/12/17
MSCN
09/12/17
NO CHANGE
MSCN
MScience establishes McDonald's Q3 US sales estimate below consensus
Shares of McDonald's are trading lower following MScience establishing a Q3 US sales estimate of $9.49B, versus consensus of $9.56B.
09/12/17
MSCN
09/12/17
NO CHANGE
MSCN
McDonald's mentioned cautiously at MScience
09/08/17
BMOC
09/08/17
NO CHANGE
BMOC
Fast food restaurants more insulated from Amazon effects, says BMO Capital
BMO Capital says that fast food companies "are likely more insulated" from Amazon (AMZN) than other types of restaurants "due to their convenience-based usage occasions, low price points, and insulation from deflationary pressures." The firm identifies Wendy's (WEN) and McDonald's (MCD) as its favorite names in the fast food space.
PM Philip Morris
$111.70

0.0865 (0.08%)

09/28/17
GSCO
09/28/17
UPGRADE
Target $135
GSCO
Conviction Buy
Philip Morris upgraded to Conviction Buy from Buy at Goldman Sachs
Goldman Sachs analyst Judy Hong upgraded Philip Morris (PM) to Conviction Buy and reiterates the stock as her top pick in within tobacco. The company offers a "rare innovation product cycle story within Staples" along with the strongest global positioning in next generation products, Hong tells investors in a research note where she also upgraded Brown-Forman (BF.B) to Neutral. The analyst views Philip Morris' IQOS as a "game-changer for Global Tobacco." She raised her price target for the shares to $135 from $133. Hong also highlights Mondelez (MDLZ), Estee Lauder (EL) and Kimberly-Clark (KMB) as top multinational picks.
09/26/17
COWN
09/26/17
UPGRADE
COWN
Outperform
British American Tobacco upgraded to Outperform at Cowen
As reported previously, Cowen analyst Vivien Azer upgraded British American Tobacco (BTI) to Outperform from Market Perform as she views the weakness from FDA risk and foreign exchange movements as having created an attractive entry point. She said given its consistent market share gains and earnings growth, the stock's discount to Philip Morris (PM) looks overdone.
09/06/17
PIPR
09/06/17
NO CHANGE
Target $135
PIPR
Overweight
Piper positive on Philip Morris after iQOS checks in Europe
Piper Jaffray analyst Michael Lavery says his European channel checks show strong momentum on iQOS, Philip Morris' heated tobacco product. Visits to Serbia, Russia, and Poland indicated iQOS has a better than expected presence, Lavery tells investors in a research note. The analyst is more bullish on the company's potential for incremental earnings from iQOS and continues to believe his earnings estimates for Philip Morris are likely to be conservative. Lavery raised his price target for the shares to $135 from $134 and keeps an Overweight rating on the name.
08/30/17
MSCO
08/30/17
NO CHANGE
MSCO
Overweight
British American Tobacco recent weakness appears overdone, says Morgan Stanley
Morgan Stanley analyst Matthew Grainger said he views some degree of weakness in U.S. and European tobacco stocks since "FDA Friday" - when the agency announced plan to pursue reduced nicotine content in cigarettes - as warranted, but he views the impact on British American Tobacco (BTI) as being overstated by the stock's 11% pullback. For Altria Group (MO), which is down 14% since that day, he sees the move as having returned the stock to appropriate valuation levels, he added. Grainger lowered his price target for Altria to $65 from $68, kept his Philip Morris (PM) price target of $120 unchanged and maintains his British American target at GBP60.
BLK BlackRock
$441.64

3.24 (0.74%)

09/15/17
JPMS
09/15/17
NO CHANGE
Target $551
JPMS
Overweight
BlackRock shares will hold up in market correction, says JPMorgan
BlackRock shares will hold up better than peers in a U.S. market correction, JPMorgan analyst Kenneth Worthington tells investors in a research note. The analyst notes that with U.S. equity markets reaching all-time highs, he increasingly hears investor concerns about investing in asset managers. He believes BlackRock has demonstrated that it can maintain positive sales and organic growth even when equity U.S. markets sell off. The analyst keeps an Overweight rating on the shares with a $551 price target.
09/08/17
LEHM
09/08/17
INITIATION
Target $475
LEHM
Overweight
BlackRock initiated with an Overweight at Barclays
Barclays analyst Jeremy Campbell started BlackRock with an Overweight rating and $475 price target. The analyst initiated U.S. Brokers, Asset Managers & Exchanges with a Neutral industry view.
07/18/17
FBCO
07/18/17
NO CHANGE
Target $534
FBCO
Outperform
BlackRock price target lowered to $534 from $545 at Credit Suisse
Credit Suisse analyst Craig Siegenthaler lowered his price target for BlackRock to $534 from $545 following Q2 results. Nonetheless, the analyst reiterates an Outperform rating on the shares as he forecasts record net flows in 2017, stable-improving base fee organic growth rate and EPS growth of about 15% over the next few years.
09/28/17
GSCO
09/28/17
UPGRADE
Target $500
GSCO
Conviction Buy
BlackRock upgraded to Conviction Buy from Buy at Goldman Sachs
Goldman analyst Alexander Blostein upgraded BlackRock and added it to the Conviction Buy List with a $500 price target. The analyst has expects an acceleration in annual operating income growth given improving trends in active, easing pressures on blended fee rates, and scaling of its Tech platform which should lead to sustainable multiple improvement.
PBPB Potbelly
$11.50

-0.1 (-0.86%)

05/31/17
05/31/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Donaldson (DCI) upgraded to Buy from Hold at Jefferies with analyst Laurence Alexander saying he sees "increasing evidence" the company's end-markets are exiting the multi-year trough and believes operating leverage should translate into above-average compound growth over the next few years. He recommends building positions in the stock during the second half of 2017. 2. VMware (VMW) upgraded to Outperform from Neutral at Baird with analyst Jason Noland citing the company's strategic shift to partner with firms rather than compete with the public cloud. 3. Akari Therapeutics (AKTX) upgraded to Neutral from Sell at Chardan. 4. Vale (VALE) upgraded to Buy from Hold at HSBC with analyst Jonathan Brandt saying the recent decline in iron ore prices has mitigated risk, and the focus should now shift to the company's "strong" free cash flow generation and 6% dividend yield. 5. Potbelly (PBPB) upgraded to Buy from Hold at Maxim with analyst Stephen Anderson citing news that Chief Executive Officer Aylwin Lewis is resigning, as he believes new management could reinvigorate performance. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/28/17
PIPR
09/28/17
UPGRADE
Target $17
PIPR
Overweight
Potbelly upgraded to Overweight from Neutral at Piper Jaffray
Piper Jaffray analyst Nicole Miller Regan upgraded Potbelly to Overweight and raised her price target for the shares to $17 from $12. The analyst believes a "compelling" turnaround is building. She sees "several catalysts" upcoming, including improving same-store sales from a focus on the brand's core lunch positioning and earnings accretion from share repurchases.
07/21/17
07/21/17
DOWNGRADE
Target $13

Hold
Maxim cuts Potbelly to Hold, sees recovery, activism priced in
As previously reported, Maxim analyst Stephen Anderson downgraded Potbelly to Hold from Buy, stating that he believes the potential catalysts of a new CEO, activist involvement and the company's recovery have been priced in with shares approaching his unchanged price target of $13. While he expects a "modest beat" on earnings with the company's upcoming report, he does not expect Potbelly to management to raise its 2017 guidance.
07/21/17
MAXM
07/21/17
DOWNGRADE
MAXM
Hold
Potbelly downgraded to Hold from Buy at Maxim
HUN Huntsman
$26.92

-0.02 (-0.07%)

09/27/17
WELS
09/27/17
UPGRADE
WELS
Outperform
Huntsman upgraded to Outperform from Market Perform at Wells Fargo
09/28/17
WELS
09/28/17
UPGRADE
Target $32
WELS
Outperform
Huntsman upgraded to Outperform from Market Perform at Wells Fargo
Wells Fargo analyst Frank Mitsch upgraded Huntsman to Outperform saying the recent weakness in the shares is a buying opportunity. The collapse of the Clariant merger would be an "additional positive" given Huntsman's "better-than-ever" balance sheet, cash generation prospects and standalone businesses' potential, Mitsch tells investors in a research note after meeting with management. The analyst raised his price target for the shares to $32 from $30.
07/24/17
07/24/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Huntsman (HUN) upgraded to Overweight from Sector Weight at KeyBanc with analyst Michael Sison saying he believes HuntsmanClariant will generate "attractive earnings growth" through the end of the decade. He also sees the IPO of Venator (VNTR) as a potential catalyst. 2. Caterpillar (CAT) upgraded to Outperform from Market Perform at BMO Capital with analyst Joel Tiss saying he expects the company to provide five year Earnings Per Share guidance at its September investor event "that could approach" his $16 outlook. 3. Michaels (MIK) upgraded to Overweight from Neutral at JPMorgan with analyst Christopher Horvers saying the risk/reward at current share levels is attractive. 4. Xerox (XRX) upgraded to Equal Weight from Underweight at Barclays with analyst Mark Moskowitz saying better market conditions and cost take-outs could help the company improve revenue and margins. 5. Leggett & Platt (LEG) upgraded to Long-Term Buy from Neutral at Hilliard Lyons with analyst Spencer Joyce saying the upgrade is not a call on Q2 results, but does expect positive commentary toward second half 2017 and believes valuation provides a compelling long-term entry point. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/24/17
KEYB
07/24/17
UPGRADE
Target $34
KEYB
Overweight
Huntsman upgraded to Overweight from Sector Weight at KeyBanc
KeyBanc analyst Michael Sison upgraded Huntsman to Overweight with a $34 price target. The analyst believes HuntsmanClariant will generate "attractive earnings growth" through the end of the decade. He also sees the IPO of Venator as a potential catalyst.

TODAY'S FREE FLY STORIES

SYNT

Syntel

$24.30

5.2 (27.23%)

20:37
10/17/17
10/17
20:37
10/17/17
20:37
Upgrade
Syntel rating change at William Blair »

Syntel upgraded to Market…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 17

    Oct

  • 18

    Oct

  • 19

    Oct

  • 14

    Dec

QD

Qudian

20:35
10/17/17
10/17
20:35
10/17/17
20:35
Syndicate
Qudian 37.5M share IPO priced at $24.00 »

The deal priced above the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

ABT

Abbott

$55.06

0.43 (0.79%)

, USB

U.S. Bancorp

$53.88

-0.38 (-0.70%)

20:25
10/17/17
10/17
20:25
10/17/17
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

ABT

Abbott

$55.06

0.43 (0.79%)

USB

U.S. Bancorp

$53.88

-0.38 (-0.70%)

SVU

Supervalu

$19.38

0.57 (3.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 18

    Oct

  • 18

    Oct

  • 17

    Jan

UNH

UnitedHealth

$203.89

10.69 (5.53%)

19:58
10/17/17
10/17
19:58
10/17/17
19:58
Recommendations
UnitedHealth analyst commentary at Piper Jaffray »

UnitedHealth price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

19:25
10/17/17
10/17
19:25
10/17/17
19:25
Conference/Events
The Heritage Foundation hosts President Trump »

President Trump speaks at…

SINA

Sina

$114.26

-0.73 (-0.63%)

19:18
10/17/17
10/17
19:18
10/17/17
19:18
Hot Stocks
Aristeia: Sina claims 'inaccurate' and 'misleading' »

Aristeia Capital, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Nov

CLDR

Cloudera

$15.51

0.13 (0.85%)

, HTHIY

Hitachi

$75.56

-0.49 (-0.64%)

18:57
10/17/17
10/17
18:57
10/17/17
18:57
Hot Stocks
Cloudera, Hitachi form strategic partnership »

Cloudera (CLDR) announced…

CLDR

Cloudera

$15.51

0.13 (0.85%)

HTHIY

Hitachi

$75.56

-0.49 (-0.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PNFP

Pinnacle Financial

$65.15

-1.15 (-1.73%)

18:35
10/17/17
10/17
18:35
10/17/17
18:35
Earnings
Pinnacle Financial reports Q3 adjusted EPS 90c, consensus 74c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 15

    Nov

FULT

Fulton Financial

$18.95

-0.3 (-1.56%)

18:07
10/17/17
10/17
18:07
10/17/17
18:07
Hot Stocks
Fulton Financial sees FY17 loans & deposits growth mid to high single digits »

Sees FY17 non-interest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 01

    Nov

  • 02

    Nov

EXXI

Energy XXI

$8.59

-0.41 (-4.56%)

18:07
10/17/17
10/17
18:07
10/17/17
18:07
Hot Stocks
Energy XXI provides operational update on Hurricane Nate impact »

Energy XXI provided an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FULT

Fulton Financial

$18.95

-0.3 (-1.56%)

18:07
10/17/17
10/17
18:07
10/17/17
18:07
Hot Stocks
Fulton Financial cuts Q4 net interest margin view to up 2-6 bp from 3-9 »

Cuts Q4 non-interest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 01

    Nov

  • 02

    Nov

HGV

Hilton Grand Vacations

$39.83

0.05 (0.13%)

17:45
10/17/17
10/17
17:45
10/17/17
17:45
Hot Stocks
Hilton Grand Vacations acquires Sunrise Lodge, terms not disclosed »

Hilton Grand Vacations…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

PRGX

PRGX Global

$6.80

0.05 (0.74%)

, KR

Kroger

$20.48

0.04 (0.20%)

17:42
10/17/17
10/17
17:42
10/17/17
17:42
Hot Stocks
PRGX Global signs multi-year technology services contract with Kroger »

PRGX Global (PRGX) signed…

PRGX

PRGX Global

$6.80

0.05 (0.74%)

KR

Kroger

$20.48

0.04 (0.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

  • 14

    Dec

UBFO

United Security Bank

$9.50

-0.05 (-0.52%)

17:38
10/17/17
10/17
17:38
10/17/17
17:38
Earnings
United Security Bank reports Q3 EPS 16c versus 12c in year-ago period »

Reports Q3 NII $8.2M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UBSH

Union Bankshares

$35.32

-0.18 (-0.51%)

, XBKS

Xenith Bankshares

$32.77

-0.07 (-0.21%)

17:35
10/17/17
10/17
17:35
10/17/17
17:35
Hot Stocks
Xenith Bankshares merger into Union Bankshares receives regulatory approval »

Union Bankshares (UBSH)…

UBSH

Union Bankshares

$35.32

-0.18 (-0.51%)

XBKS

Xenith Bankshares

$32.77

-0.07 (-0.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 15

    Nov

OMAB

OMA Airports

$41.34

0.28 (0.68%)

17:35
10/17/17
10/17
17:35
10/17/17
17:35
Hot Stocks
OMA Airports reports Q3 terminal passenger traffic up 1.3% »

Aeronautical revenues per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBM

IBM

$146.54

-0.29 (-0.20%)

17:34
10/17/17
10/17
17:34
10/17/17
17:34
Earnings
IBM sees $2.8B-$2.9B increase in Q4 sales from Q3 »

Sees $300M-$400M boost…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 22

    Oct

  • 15

    Nov

OMAB

OMA Airports

$41.34

0.28 (0.68%)

17:33
10/17/17
10/17
17:33
10/17/17
17:33
Earnings
OMA Airports reports Q3 EPS 66c, consensus 70c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCSS

Select Comfort

$30.38

-0.17 (-0.56%)

17:33
10/17/17
10/17
17:33
10/17/17
17:33
Hot Stocks
Breaking Hot Stocks news story on Select Comfort »

Select Comfort says sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

IBM

IBM

$146.54

-0.29 (-0.20%)

, IBKR

Interactive Brokers

$47.40

-0.32 (-0.67%)

17:32
10/17/17
10/17
17:32
10/17/17
17:32
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS: IBM…

IBM

IBM

$146.54

-0.29 (-0.20%)

IBKR

Interactive Brokers

$47.40

-0.32 (-0.67%)

SSKN

STRATA Skin Sciences

$1.75

-0.04 (-2.23%)

HCLP

Hi-Crush Partners

$8.95

0.25 (2.87%)

SCSS

Select Comfort

$30.38

-0.17 (-0.56%)

NAVI

Navient

$12.20

0.47 (4.01%)

CREE

Cree

$29.34

0.06 (0.20%)

AKTX

Akari Therapeutics

$6.40

-0.08 (-1.23%)

MOBL

MobileIron

$3.80

-0.1 (-2.56%)

FOGO

Fogo De Chao

$12.05

0.1 (0.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 18

    Oct

  • 22

    Oct

  • 01

    Nov

  • 15

    Nov

  • 18

    Oct

IBM

IBM

$146.54

-0.29 (-0.20%)

17:32
10/17/17
10/17
17:32
10/17/17
17:32
Hot Stocks
IBM sees increase in gross margin of 2.5 points from Q3 to Q4 »

Says not yet feeling full…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 22

    Oct

  • 15

    Nov

PAYX

Paychex

$62.90

-0.55 (-0.87%)

17:31
10/17/17
10/17
17:31
10/17/17
17:31
Syndicate
Breaking Syndicate news story on Paychex »

Paychex files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 25

    Oct

VZ

Verizon

$48.40

0.31 (0.64%)

17:24
10/17/17
10/17
17:24
10/17/17
17:24
Hot Stocks
FCC settles New York City E-rate investigation with Verizon »

The Federal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 01

    Nov

SCSS

Select Comfort

$30.38

-0.17 (-0.56%)

17:20
10/17/17
10/17
17:20
10/17/17
17:20
Hot Stocks
Breaking Hot Stocks news story on Select Comfort »

Select Comfort expects to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

IBM

IBM

$146.54

-0.29 (-0.20%)

17:17
10/17/17
10/17
17:17
10/17/17
17:17
Hot Stocks
IBM: Global business services signings up for 3rd consecutive quarter »

Says cognitive solutions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 22

    Oct

  • 15

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.